462 related articles for article (PubMed ID: 15586384)
1. Regulation of 11beta-hydroxysteroid dehydrogenase type 1 and glucose-stimulated insulin secretion in pancreatic islets of Langerhans.
Ortsäter H; Alberts P; Warpman U; Engblom LO; Abrahmsén L; Bergsten P
Diabetes Metab Res Rev; 2005; 21(4):359-66. PubMed ID: 15586384
[TBL] [Abstract][Full Text] [Related]
2. 11beta-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets.
Swali A; Walker EA; Lavery GG; Tomlinson JW; Stewart PM
Diabetologia; 2008 Nov; 51(11):2003-11. PubMed ID: 18779947
[TBL] [Abstract][Full Text] [Related]
3. Decreased 11β-Hydroxysteroid Dehydrogenase 1 Level and Activity in Murine Pancreatic Islets Caused by Insulin-Like Growth Factor I Overexpression.
Chowdhury S; Grimm L; Gong YJ; Wang B; Li B; Srikant CB; Gao ZH; Liu JL
PLoS One; 2015; 10(8):e0136656. PubMed ID: 26305481
[TBL] [Abstract][Full Text] [Related]
4. Leptin activation of corticosterone production in hepatocytes may contribute to the reversal of obesity and hyperglycemia in leptin-deficient ob/ob mice.
Liu Y; Nakagawa Y; Wang Y; Li R; Li X; Ohzeki T; Friedman TC
Diabetes; 2003 Jun; 52(6):1409-16. PubMed ID: 12765951
[TBL] [Abstract][Full Text] [Related]
5. Type 1 11beta -hydroxysteroid dehydrogenase mediates glucocorticoid activation and insulin release in pancreatic islets.
Davani B; Khan A; Hult M; Mårtensson E; Okret S; Efendic S; Jörnvall H; Oppermann UC
J Biol Chem; 2000 Nov; 275(45):34841-4. PubMed ID: 10973946
[TBL] [Abstract][Full Text] [Related]
6. Emodin, an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, regulates adipocyte function in vitro and exerts anti-diabetic effect in ob/ob mice.
Wang YJ; Huang SL; Feng Y; Ning MM; Leng Y
Acta Pharmacol Sin; 2012 Sep; 33(9):1195-203. PubMed ID: 22922341
[TBL] [Abstract][Full Text] [Related]
7. Increased glucocorticoid receptor and 11{beta}-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice.
Liu Y; Nakagawa Y; Wang Y; Sakurai R; Tripathi PV; Lutfy K; Friedman TC
Diabetes; 2005 Jan; 54(1):32-40. PubMed ID: 15616008
[TBL] [Abstract][Full Text] [Related]
8. 11-Dehydrocorticosterone causes metabolic syndrome, which is prevented when 11β-HSD1 is knocked out in livers of male mice.
Harno E; Cottrell EC; Keevil BG; DeSchoolmeester J; Bohlooly-Y M; Andersén H; Turnbull AV; Leighton B; White A
Endocrinology; 2013 Oct; 154(10):3599-609. PubMed ID: 23832962
[TBL] [Abstract][Full Text] [Related]
9. In obese mice, exercise training increases 11β-HSD1 expression, contributing to glucocorticoid activation and suppression of pulmonary inflammation.
Du SF; Yu Q; Chuan K; Ye CL; He ZJ; Liu SJ; Zhu XY; Liu YJ
J Appl Physiol (1985); 2017 Oct; 123(4):717-727. PubMed ID: 28663379
[TBL] [Abstract][Full Text] [Related]
10. Short-term glucocorticoid treatment increases insulin secretion in islets derived from lean mice through multiple pathways and mechanisms.
Hult M; Ortsäter H; Schuster G; Graedler F; Beckers J; Adamski J; Ploner A; Jörnvall H; Bergsten P; Oppermann U
Mol Cell Endocrinol; 2009 Mar; 301(1-2):109-16. PubMed ID: 18984029
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue and portal hypercortisolism in non-alcoholic fatty liver disease.
Candia R; Riquelme A; Baudrand R; Carvajal CA; Morales M; Solís N; Pizarro M; Escalona A; Carrasco G; Boza C; Pérez G; Padilla O; Cerda J; Fardella CE; Arrese M
Liver Int; 2012 Mar; 32(3):392-9. PubMed ID: 22136330
[TBL] [Abstract][Full Text] [Related]
12. 11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle.
Morgan SA; Sherlock M; Gathercole LL; Lavery GG; Lenaghan C; Bujalska IJ; Laber D; Yu A; Convey G; Mayers R; Hegyi K; Sethi JK; Stewart PM; Smith DM; Tomlinson JW
Diabetes; 2009 Nov; 58(11):2506-15. PubMed ID: 19675138
[TBL] [Abstract][Full Text] [Related]
13. 11β-Hydroxysteroid dehydrogenase type 1 selective inhibitor BVT.2733 protects osteoblasts against endogenous glucocorticoid induced dysfunction.
Wu L; Qi H; Zhong Y; Lv S; Yu J; Liu J; Wang L; Bi J; Kong X; Di W; Zha J; Liu F; Ding G
Endocr J; 2013; 60(9):1047-58. PubMed ID: 23759754
[TBL] [Abstract][Full Text] [Related]
14. Time of the day for 11beta-HSD1 inhibition plays a role in improving glucose homeostasis in DIO mice.
Véniant MM; Hale C; Komorowski R; Chen MM; St Jean DJ; Fotsch C; Wang M
Diabetes Obes Metab; 2009 Feb; 11(2):109-17. PubMed ID: 18479468
[TBL] [Abstract][Full Text] [Related]
15. Effect of high-fat diet on KKAy and ob/ob mouse liver and adipose tissue corticosterone and 11-dehydrocorticosterone concentrations.
Alberts P; Rönquist-Nii Y; Larsson C; Klingström G; Engblom L; Edling N; Lidell V; Berg I; Edlund PO; Ashkzari M; Sahaf N; Norling S; Berggren V; Bergdahl K; Forsgren M; Abrahmsén L
Horm Metab Res; 2005 Jul; 37(7):402-7. PubMed ID: 16034710
[TBL] [Abstract][Full Text] [Related]
16. 11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue.
Wang Y; Yan C; Liu L; Wang W; Du H; Fan W; Lutfy K; Jiang M; Friedman TC; Liu Y
Am J Physiol Endocrinol Metab; 2015 Jan; 308(1):E84-95. PubMed ID: 25389364
[TBL] [Abstract][Full Text] [Related]
17. Threshold for glucose-stimulated insulin secretion in pancreatic islets of genetically obese (ob/ob) mice is abnormally low.
Chen NG; Tassava TM; Romsos DR
J Nutr; 1993 Sep; 123(9):1567-74. PubMed ID: 8360782
[TBL] [Abstract][Full Text] [Related]
18. Optimal elevation of β-cell 11β-hydroxysteroid dehydrogenase type 1 is a compensatory mechanism that prevents high-fat diet-induced β-cell failure.
Turban S; Liu X; Ramage L; Webster SP; Walker BR; Dunbar DR; Mullins JJ; Seckl JR; Morton NM
Diabetes; 2012 Mar; 61(3):642-52. PubMed ID: 22315313
[TBL] [Abstract][Full Text] [Related]
19. Memory deficits in a juvenile rat model of type 1 diabetes are due to excess 11β-HSD1 activity, which is upregulated by high glucose concentrations rather than insulin deficiency.
Brossaud J; Bosch-Bouju C; Marissal-Arvy N; Campas-Lebecque MN; Helbling JC; Webster SP; Walker BR; Fioramonti X; Ferreira G; Barat P; Corcuff JB; Moisan MP
Diabetologia; 2023 Sep; 66(9):1735-1747. PubMed ID: 37300580
[TBL] [Abstract][Full Text] [Related]
20. A novel highly potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, INU-101.
Hong SP; Han D; Chang KH; Ahn SK
Eur J Pharmacol; 2018 Sep; 835():169-178. PubMed ID: 30096297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
